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Abstract
Background: In patients with mild to moderate left ventricular dysfunction (LVD) (35% £ LVEF
£ 50%) who present with syncope, demonstration of tachy and/or brady-arrhythmia has
prognostic value. In this group of patients electrophysiological study (EPS) is often necessary.
Methods: A total of 53 consecutive patients with mild to moderate LVD and history of
undetermined syncope underwent EPS. Sinus node function, His-Purkinje system conduction
and ventricular electrical stability were evaluated.
Results: Twenty eight patients (52.8%) had induction of sustained monomorphic ventricular
tachycardia (VT) and five (9.4%) patients had a sustained ventricular arrhythmia other than
monomorphic VT (ventricular flutter, ventricular fibrillation, and polymorphic VT) induced
during EPS. Abnormal sinus node function and/or His-Purkinje system conduction was
found in five (9.4%) patients. Age, gender, history of myocardial infarction, type of underlying
heart disease and history of revascularization were not predictors of VT induction. Wide QRS
morphology independently, and lower left ventricular ejection fraction and presence of
pathologic q wave in precordial leads dependently, could increase risk of VT induction.
Conclusions: The EPS can determine which patient with syncope and mild to moderate LVD
is likely to benefit from placing an ICD for prevention of sudden cardiac death. Pathologic
precordial q wave, wide QRS morphology and lower left ventricular ejection fraction could be
predictors of VT induction during EPS. Wide QRS morphology has an independent effect in
this category. (Cardiol J 2009; 16, 4: 327–331)
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Introduction
Syncope is temporary loss of consciousness and
posture, usually related to temporarily insufficient
blood flow to the brain. In patients with structural
heart disease, the occurrence of syncope heralds an
increased risk of sudden arrhythmic death [1]. The
management of patients with unexplained syncope,
no documented ventricular arrhythmias and struc-
tural heart disease with mild to moderate ventricu-
lar dysfunction is not well established. After initial
clinical assessment in many patients with a history
of syncope, the underlying etiology remains unex-
plained. Although the real value of electrophysio-
logical study (EPS) in patients with unexplained
syncope, no documented ventricular arrhythmi-
as and structural heart disease, is not precisely
defined, this approach is commonly used for fur-
ther risk stratification and guided antiarrhythmia
management [2]. It is the purpose of this retro-
spective study to analyze the predictive factors
of electrophysiologically ventricular arrhythmia
induction in patients with history of unexplained




Syncope: sudden transient loss of conscious-
ness and postural tone with spontaneous recovery.
Unexplained syncope: true syncope where cardi-
ac origin is highly suspected and has no correlation with
abnormal findings in past medical history (for exam-
ple: neurally mediated syncope), physical examination
(for example: orthostatic hypotension), electrocardio-
graphy (ECG; for example: sustained ventricular tach-
ycardia or complete heart block) and echocardiogra-
phy (for example: severe aortic stenosis).
Mild to moderate LVD: left ventricular ejection
fraction (LVEF) > 35% and < 50% on echocardio-
graphy in patients with coronary artery disease or
dilated cardiomyopathy.
Sustained monomorphic ventricular tachycar-
dia: ventricular tachycardia manifesting a beat to
beat uniform surface ECG QRS configuration last-
ing ≥ 30 s or that is hemodynamically intolerable
and needs termination.
Polymorphic ventricular tachycardia: ven-
tricular tachycardia that has no constant morpho-
logy for more than five complexes, has no clear iso-
electric baseline or has QRS complexes that are
asynchronous in multiple simultaneously record-
ed leads.
Ventricular fibrillation (VF): presence of irre-
gular undulations of varying contour and amplitude
and absence of distinct QRS complexes, ST seg-
ments and T waves.
Old anterior wall infarction: diagnosed by the
presence of initial deep and broad q waves in any
two consecutive precordial leads.
Old inferior wall infarction: diagnosed by the
presence of initial deep and broad q waves in at least
two of three inferior leads (II, III and aVF).
Study populations
We evaluated 53 consecutive patients (male/
/female: 43/10) with unexplained syncope and mild
to moderate LVD between April 2004 and April
2008. Inclusion criteria were:
— one or more episodes of unexplained syncope;
— no documented ventricular arrhythmias on
surface ECG or Holter monitoring;




— history of any episode of tachycardia;
— history of cardiac arrest;
— diagnosis of long QT syndrome;
— susceptibility to neurally mediated syncope.
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Measurement of left ventricular function
A complete M-mode and two-dimensional ima-
ging were performed using an ultrasonographic
machine (Vivid 7, General Electric, Wauwatosa, WI,
USA). Images were obtained using a 3.5 MHz trans-
ducer at a depth of 16 cm in the parasternal and
apical views (standard long axis and two and four
chamber views). Left ventricular end-systolic and
diastolic dimensions and volumes and LVEF were
calculated using the biplane Simpson’s technique.
Patients with LVEF more than 35% and less than
50% were included in the study.
Electrophysiological study
After written consent was obtained, studies
were done in the fast and non-sedated state. Before
the study, all antiarrhythmic drugs were stopped for
at least five half lives. Three quadric-polar electrode
catheters were used. They were percutaneously
inserted under local anesthesia through the femo-
ral vein and positioned under fluoroscopic guidance
in the high right atrium, His bundle area and right
ventricle. Programmed ventricular stimulation
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(PVS) was performed with pulse duration of
1.5 ms at twice diastolic threshold. The PVS proto-
col utilized up to three extra-stimuli delivered dur-
ing sinus rhythm and after eight paced ventricular
cycle lengths at 550 and 400 ms. Minimum deli-
vered extra-stimuli was 200 ms. First the right ven-
tricular apex, then the right ventricular outflow tract
were tested, with and without procainamide stress
test (10 mg/kg), in case no sustained ventricular
arrhythmia was induced before.
Statistical analysis
Results are expressed as mean (SD) for inter-
val and frequency (relative frequency) for catego-
rical data. Independent sample t and c2 tests were
used for comparison between the two groups. Pear-
son correlation coefficient (r) was used to find the
linear correlation between interval data. A p value
less than 0.05 was considered statistically signifi-
cant. Logistic regression model was fitted to deter-
mine the associations between the presence and
absence of sustained ventricular arrhythmia induc-
tion during PVS in syncopal patients with mild to
moderate LVD. STATA 8 SE (STATA Corporation,
Texas, USA) was used for statistical analysis.
Results
Fifty three patients with syncope and mild to
moderate LVD underwent electrophysiological
testing. Forty three males and ten females with
a mean age of 57 ± 13.3 years were enrolled in the
study. The underlying heart disease was coronary
artery disease in 36 patients (67.9%) and non-
-ischemic dilated cardiomyopathy in 17 (32.1%).
Seventeen patients (32.1%) had a documented his-
tory of myocardial infarction. Eighteen patients
(34%) were revascularized, interventional revascu-
larization (seven patients), bypass grafting (ten pa-
tients) or both of them. Mean QRS duration was
115.7 ± 29.1 ms and mean LVEF was 40.8 ±  3.8%.
Based on surface ECG, ten (18.9%) and 12 (22.6%)
pathological q waves were detected in anterior pre-
cordial and inferior leads respectively. Abnormal
electrical conduction pattern was found in 30 patients
and categorized into the following groups: left bun-
dle branch block pattern in 14 (26.4%), right bundle
branch block pattern in four (7.5%) and intraventricu-
lar conduction delay (IVCD) in 12 (22.6%).
Predictors of ventricular
arrhythmia induction
Based on EPS results, the patients fell into two
groups. In group 1, ventricular tachyarrhythmias
were induced during EPS and in group 2 ventricu-
lar arrhythmias were not inducible. EPS could in-
duce ventricular arrhythmias in 33 (62.3%) patients
and 26 of them accepted cardioverter-defibrillator
implantation. Five patients received a permanent
pacemaker due to the sinus node, atrioventricular
node and/or His-Purkinje system abnormality. Tilt
table test was done for 12 patients after negative
EPS and was positive in four patients (mixed type
pattern in three and vasodepressor type in one).
The clinical and para-clinical characteristics of the
two study groups are detailed in Table 1. History
of myocardial infarction, presence of pathologic
q wave in anterior leads, abnormal QRS morphology
and LVEF less than 40% were predictors of ven-
tricular tachyarrhythmia induction. Logistic regres-
Table 1. Clinical and para-clinical characteristics of the two study groups.
Induced ventricular Non-induced P
arrhythmias  ventricular arrhythmias
Gender (male/female) 28/5 15/5 0.374
Age 56 ± 13.6 53.5 ± 13 0.149
Etiology (ischemic/non-ischemic)* 24/9 12/8 0.336
Post myocardial infarction status (yes/no) 14/19 3/17 0.038
Revascularized (yes/no)** 10/23 8/12 0.470
QRS duration [ms] 118.6 ± 25.7 111.0 ± 34.3 0.367
QTc interval [ms] 400.5 ± 43.3 392.9 ± 51.1 0.564
Wide QRS morphology (yes/no)*** 23/10 7/13 0.013
Pathologic q wave in anterior leads (yes/no) 9/24 1/19 0.045
Pathologic q wave in inferior leads (yes/no) 6/27 6/14 0.319
Left ventricular ejection fraction 39.9 ± 3.8% 42.2 ± 3.4% 0.028
*history of documented coronary artery disease; **history of interventional revascularization and/or aorto-coronary bypass grafting; ***abnormal
QRS morphology including: RBBB, LBBB, biphascicular block and intraventricular conduction delay
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sion model was adjusted for the following factors:
age, gender, LVEF, pathologic q waves in anterior
and/or inferior leads, abnormality of QRS morpho-
logy, etiology of LVD, history of myocardial infarc-
tion and history of revascularization. P value for
goodness-of-fit was 0.1161. Among all mentioned
factors, only abnormal QRS morphology had a sig-
nificant effect on the probability of ventricular ar-
rhythmia induction during PVS in syncopal patients
with mild to moderate LVD (Table 2).
Discussion
Using EPS, in 62.3% of our patients potential-
ly life-threatening tachyarrhythmias could be in-
duced. Reported results in the literature for induc-
tion of sustained ventricular tachyarrhythmias in
syncopal patients and organic heart disease are
about 21–50% [2–4]. Patients with positive test
results were considered at high risk of sudden ar-
rhythmic death and received implantable defibril-
lator devices [5, 6]. In our study, clinical and para-
clinical predictors of inducible ventricular tachycar-
dia during EPS were as follows: history of
myocardial infarction, presence of pathological
q wave in anterior leads, wide QRS morphology and
more depressed LVEF (less than 40%) (Table 1).
EPS has a more prognostic value in syncopal
patients with ischemic heart disease and myocar-
dial infarction [7]. Pathologic q wave in anterior
leads may be showing presence of myocardial scar
or aneurysm. In our study, this finding was a pre-
dictive factor of ventricular induction during EPS.
Pathologic q wave in inferior leads could not signif-
icantly increase risk of arrhythmia induction. This
finding can be explained with the smaller mass of
myocardial scar in the mentioned group, compar-
ing with the patients, who have pathological q wave
in the anterior leads. Left ventricular ejection frac-
tion less than 40% and wide QRS morphology were
other ominous predictors. Krol et al. [8] found sim-
ilar results in their study. They reported that in
patients with unexplained syncope, an LVEF less
than or equal to 0.40 was the most powerful pre-
dictor of a positive EPS (p less than 0.00001), fol-
lowed by the presence of bundle branch block (p less
than 0.00003), coronary artery disease (p less than
0.0003), remote myocardial infarction (p less than
0.00006), use of type 1 antiarrhythmic drugs (p less
than 0.00003), injury related to loss of conscious-
ness (p less than 0.01) and male sex (p less than
0.01). In patients with severe LVD (LVEF < 30%),
history of previous myocardial infarction and no
spontaneous ventricular tachycardia clinical varia-
bles do not have practical usefulness in identifying
patients inducible at electrophysiological testing.
These patients are candidates for cardioverter-de-
fibrillator implantation [9]. In other syncopal pa-
tients with and without history of coronary artery
disease in the presence of impaired left ventricular
function or structural heart disease, EPS is recom-
mended to evaluate electrical stability [10, 11]. In
our study, LVEF less than 40% significantly in-
creased the risk of ventricular arrhythmias induc-
tion but it was dependent on the wide QRS mor-
phology (Table 2). This finding suggests that in
syncopal patients with mild to moderate LVD,
LVEF is not per se the most powerful predictor of
ventricular arrhythmia induction during EPS. Other
factors, such as abnormal conduction and presence
of myocardial scar, can be effective in arrhythmia
induction during EPS.
Table 2. Logistic model for arrhythmia induction during electrophysiological study in syncopal patients
with mild to moderate left ventricular dysfunction.
Odds ratio P 95% confidence interval
Age 1.021211 0.477 0.9638512–1.081984
Gender 0.7210881 0.733 0.1101075–4.722368
Left ventricular dysfunction etiology 1.544607 0.726 0.1361272–17.52634
Revascularized 0.7723971 0.811 0.0926586–6.438662
Left ventricular ejection fraction 0.9568714 0.681 0.7754235–1.180778
Pathologic q wave in inferior leads 0.3198513 0.287 0.0391474–2.613322
Pathologic q wave in anterior leads 5.666612 0.278 0.246509–130.2609
QRS duration 0.9721224 0.120 0.9381292–1.007347
Abnormal QRS morphology 27.5493 0.009 2.314415–327.9291
History of myocardial infarction 3.513314 0.477 0.9638512–1.081984
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Limitations of the study
The effects of predictive factors in arrhythmia
induction should be checked during follow-up. The
p value for goodness-of-fit was nonsignificant and
the model is fit, but 95% confidence interval of wide
QRS morphology shows a wide range from 2.3 to
327 (odds ratio: 27.5) (Table 2). Increasing the sam-
ple size could reduce this wide range. Evaluation
of myocardial scar by echocardiography and/or ra-
dionuclide imaging in syncopal patients with mild
to moderate LVD may be more important than ECG
parameters like pathological q wave in anterior
leads.
Conclusions
Left ventricle impairment is an important is-
sue in syncopal patients. In patients with mild to
moderate LVD, other factors such as previous myo-
cardial infarction, presence of pathologic q wave in
precordial leads and wide QRS morphology can sig-
nificantly increase the risk of ventricular tachyar-
rhythmia induction during EPS. Among the men-
tioned factors, wide QRS morphology had an inde-
pendent effect on the risk of arrhythmia induction.
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